A rare lymphoplasmacyte-rich meningioma involving the dura of the skull base and cervical spinal cord: A case report-Reference-Cited by-同舟云学术

A rare lymphoplasmacyte-rich meningioma involving the dura of the skull base and cervical spinal cord: A case report

Published:2022-01-01 Issue:1 Volume:13 Page:470-475
ISSN:2081-6936
Container-title:Translational Neuroscience
language:en
Short-container-title:

Author:

Zhu Siyao¹,Zou Yuting¹,Wang Ya²,Xie Gongxun³,Xiao Shengying¹,Zeng Furen¹,Lu Yichen¹

Affiliation:

1. Department of Oncology, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University) , 89 Guhan Road, Furong , Changsha 410002 , PR China

2. Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University , Changsha 410013 , PR China

3. Department of Pathology, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University) , Changsha 410002 , PR China

Abstract

Abstract Lymphoplasmacyte-rich meningioma (LPRM) is a rare subtype of meningioma, the specific pathogenesis of which remains unclear. Herein, we report the case of a 48-year-old Asian man who experienced progressive deafness and limb weakness. Magnetic resonance imaging revealed extramedullary masses diffusely growing, wrapping, and compressing the cervical spinal cord. The dural lesion was partially excised by surgery, and postoperative pathological examination confirmed the diagnosis of LPRM. Diffuse LPRM is extremely rare, and its treatment is challenging owing to difficulties associated with surgery and the uncertain efficacy of traditional therapies. Therefore, further clinical practice and basic research are needed to improve the prognosis of diffuse LPRM.

Publisher

Walter de Gruyter GmbH

Subject

General Neuroscience

Link

https://www.degruyter.com/document/doi/10.1515/tnsci-2022-0263/pdf

Reference18 articles.

1. Gritsch S, Batchelor TT, Gonzalez Castro LN. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system. Cancer. 2022;128(1):47–58.

2. Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet. 2004;363(9420):1535–43.

3. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20.

4. Apra C, Peyre M, Kalamarides M. Current treatment options for meningioma. Expert Rev Neurother. 2018;18(3):241–9.

5. Tao X, Wang K, Dong J, Hou Z, Wu Z, Zhang J, et al. Clinical, radiologic, and pathologic features of 56 cases of intracranial lymphoplasmacyte-rich meningioma. World Neurosurg. 2017;106:152–64.